Lack of evidence for a harmful effect of sodium‐glucose co‐transporter 2 ( <scp>SGLT2</scp> ) inhibitors on fracture risk among type 2 diabetes patients: a network and cumulative meta‐analysis of randomized controlled trials

Abstract

Our meta-analysis based on available RCT data does not support the harmful effect of SGLT2 inhibitors on fractures, although future safety monitoring from RCTs and real-world data with detailed information on bone health is warranted.